CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $16,999,000 | +21.2% | 4,497,042 | 0.0% | 0.78% | +44.6% |
| Q2 2018 | $14,031,000 | +25.1% | 4,497,042 | -4.2% | 0.54% | +0.7% |
| Q1 2018 | $11,215,000 | -26.3% | 4,692,343 | +20.6% | 0.54% | -45.6% |
| Q4 2017 | $15,219,000 | +30.3% | 3,892,343 | -16.0% | 0.99% | +8.8% |
| Q3 2017 | $11,682,000 | +11.2% | 4,635,745 | +21.8% | 0.91% | -31.7% |
| Q2 2017 | $10,501,000 | +41.5% | 3,804,745 | 0.0% | 1.33% | +39.9% |
| Q1 2017 | $7,419,000 | +519.3% | 3,804,745 | +233.4% | 0.95% | +291.7% |
| Q4 2016 | $1,198,000 | -26.7% | 1,141,149 | +107.2% | 0.24% | -78.2% |
| Q4 2014 | $1,635,000 | – | 550,670 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |